Milestone Scientific Announces Promotion of Arjan Haverhals to CEO
Finance veteran Scott Kahn appointed CFO Leonard Osser elected Vice Chairman of the Board of Directors ROSELAND, N.J., May 13,...
News
ORYZON to Present New Clinical Data and Corporate Updates at International Conferences in May and June
BioEquity Europe DigitalOxford Global’s Online Drug Discovery WeekJefferies Virtual Healthcare Conference 2021Precision in Drug Discovery & Preclinical Virtual SummitEuropean Hematology Association...
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies
Expanded capabilities in company’s Immunogenicity and Immuno-oncology QSP Simulators broaden applicability for addressing safety and efficacy challengesPRINCETON, N.J., May 13, 2021...
Equillium Announces Oral Presentation Highlighting Positive Data from the EQUATE Study in Acute Graft-Versus-Host Disease at the EHA2021 Virtual Congress of the European Hematology Association
LA JOLLA, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to...
Beyond Air® Presents Data in Hospitalized Patients with Viral Lung Infections (including COVID-19) from LungFit® PRO Programs at ATS 2021
Interim analysis from the ongoing, open-label, randomized acute viral pneumonia (including COVID-19) pilot study shows 150 ppm nitric oxide (NO)...
BioCardia Reports First Quarter 2021 Financial Results and Business Highlights
SAN CARLOS, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a leader in the development of comprehensive solutions for...
Xtant Medical to Present at the Canaccord Musculoskeletal Conference
BELGRADE, Mont., May 13, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company...
Merus Announces Collaborations in Israel, Italy and Spain to Increase Screening and Identification of Cancer Patients with NRG1 Fusion Tumors and to Raise Awareness of the Phase 1/2 eNRGy Clinical Trial
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing...
Vyant Bio Announces Investor Conference Call and Webcast for First Quarter 2021
CHERRY HILL, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is focused on integrating...
Catalyst Biosciences to Present at the Truist Securities Life Sciences Summit
SOUTH SAN FRANCISCO, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that members of...
Innovation Pharma Files Form 10-Q; Patient Enrollment in Phase 2 Clinical Trial of Brilacidin for COVID-19 Tops 70 Percent
WAKEFIELD, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces...
Protara Therapeutics to Participate in Upcoming Virtual Investor Conferences
NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the...
Vivos Therapeutics Schedules First Quarter 2021 Financial Results Conference Call
Call Scheduled for Monday, May 17, 2021 at 5:00 pm ETHIGHLANDS RANCH, Colo., May 13, 2021 (GLOBE NEWSWIRE) -- Vivos...
Spero Therapeutics to Participate at the Berenberg Conference USA
CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on...
Daré Bioscience Reports First Quarter 2021 Financial Results and Provides a Company Update
Conference Call and Webcast Today at 4:30 p.m. Eastern TimeSAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:...
CarolinasDentist Announces Opening of New Location in Chapel Hill
Chapel Hill location marks CarolinasDentist’s 9th office in North CarolinaCHAPEL HILL, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- CarolinasDentist is...
CymaBay Welcomes Dennis D. Kim, MD, MBA as Chief Medical Officer
Experienced Biotech Executive, Physician-Scientist and Orphan Disease Expert to Lead Clinical/Medical Functions as Seladelpar Advances in Phase 3 and as...
Sunshine Biopharma Reports Improved Cash Position in 2021Q1 Filing
MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research,...
Selecta Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
SEL-399 (empty AAV8 capsid with ImmTOR) study on track with topline data expected in the fourth quarter of 2021SEL-212 enrollment...
Evaxion Biotech Announces Q1 2021 Financial Results and Provides Business Update
Raised net proceeds of $27.9 million in U.S. initial public offering in February 2021Lead programs EVX-01 and EVX-02 on track...